We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Staar Surgical Co (STAA) COM STK USD0.01

Sell:$45.90 Buy:$47.80 Change: $0.23 (0.50%)
NASDAQ:1.11%
Market closed |  Prices as at close on 22 April 2024 | Switch to live prices |
Sell:$45.90
Buy:$47.80
Change: $0.23 (0.50%)
Market closed |  Prices as at close on 22 April 2024 | Switch to live prices |
Sell:$45.90
Buy:$47.80
Change: $0.23 (0.50%)
Market closed |  Prices as at close on 22 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.

Contact details

Address:
25651 Atlantic Ocean Drive
LAKE FOREST
92630
United States
Telephone:
+1 (626) 3037902
Website:
https://www.staar.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
STAA
ISIN:
US8523123052
Market cap:
$2.27 billion
Shares in issue:
48.87 million
Sector:
Health Care Supplies
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Thomas Frinzi
    Chairman of the Board, President, Chief Executive Officer
  • Patrick Williams
    Chief Financial Officer
  • Warren Foust
    Chief Operating Officer
  • James Francese
    Senior Vice President - Commercial Operations, North America and APAC
  • Robert Studholme
    Senior Vice President - Operations
  • Keith Holliday
    Chief Technology Officer
  • Scott Barnes
    Chief Medical Officer
  • Samuel Gesten
    Chief Legal Officer, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.